Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid

Biochem J. 1990 May 15;268(1):91-8. doi: 10.1042/bj2680091.

Abstract

Theophylline and 1-methyl-3-isobutylxanthine (MIX), compounds that block eicosanoid formation and modulate phospholipase A2 activity, inhibited in a dose-dependent manner the formation of both leukotriene B4 (LTB4) and platelet-activating factor (PAF) by human polymorphonuclear leucocytes (PMN) in response to ionophore A23187. Theophylline and MIX lacked any inhibitory effect on acetyl-CoA: lyso-PAF acetyltransferase activity, which is the rate-limiting step for PAF biosynthesis in PMN. The effect of theophylline and MIX on PAF formation could be reversed by incubating the cells in the presence of 1-10 microM exogenous lyso-PAF. Incubation of PMN homogenates in the presence of unsaturated non-esterified fatty acids resulted in dose-dependent inhibition of the acetyltransferase. This effect was linked to the presence of a free carboxyl group, since both arachidonic acid methyl ester and palmitoyl-arachidonoyl phosphatidylcholine lacked inhibitory activity. This inhibitory effect was also dependent on the number of double bonds, since arachidonic acid (C20:4) and eicosapentaenoic acid (C20:5) displayed maximal effect. Kinetic analysis showed that the effect of arachidonic acid was consistent with competitive inhibition, with a Ki value of about 19 microM. Oxidative metabolites of arachidonic acid showed a lesser inhibitory effect with the following order of potency: arachidonic acid greater than 15-HETE (15-hydroxy-6,8,11,14-eicosatetraenoic acid) greater than LTB4 greater than 5-HETE (5-hydroxy-6,8,11,14-eicosatetraenoic acid) greater than lipoxin A4. Examination of enzymes involved in CoA-dependent acylation revealed a low activity of both arachidonoyl-CoA synthetase and arachidonoyl-CoA: lyso-PAF arachidonoyltransferase. These data indicate a strong influence on PAF biosynthesis of the products of the phospholipase A2 reaction, with lyso-PAF disposal being a critical event for PAF formation, and unsaturated fatty acids acting as feed-back inhibitors. The conversion of arachidonic acid via oxidative metabolism into less active inhibitors of acetyl-CoA:lyso-PAF acetyltransferase seems to be an additional mechanism of modulation of this enzyme activity, linked to the function of lipoxygenases. Finally, the enzyme activities involved in arachidonoyl-CoA-dependent acylation of lyso-PAF show a low efficiency in capturing arachidonic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Acetyltransferases / antagonists & inhibitors
  • Acetyltransferases / metabolism
  • Acyltransferases / metabolism
  • Arachidonic Acid
  • Arachidonic Acids / metabolism*
  • Arachidonic Acids / pharmacology
  • Calcimycin / pharmacology
  • Coenzyme A Ligases / metabolism
  • Fatty Acids / pharmacology
  • Humans
  • Kinetics
  • Leukotriene B4 / biosynthesis
  • Neutrophils / drug effects
  • Neutrophils / metabolism*
  • Platelet Activating Factor / analogs & derivatives*
  • Platelet Activating Factor / biosynthesis*
  • Platelet Activating Factor / metabolism
  • Platelet Activating Factor / pharmacology
  • Theophylline / pharmacology

Substances

  • Arachidonic Acids
  • Fatty Acids
  • O-deacetyl platelet activating factor
  • Platelet Activating Factor
  • Leukotriene B4
  • Arachidonic Acid
  • Calcimycin
  • Theophylline
  • Acyltransferases
  • Acetyltransferases
  • 2-acylglycerophosphate acyltransferase
  • 1-alkylglycerophosphocholine acetyltransferase
  • Coenzyme A Ligases
  • arachidonate - CoA ligase
  • 1-Methyl-3-isobutylxanthine